Gibson, Dunn & Crutcher LLP has advised US WorldMeds on the transaction, and Ropes & Gray LLP has advised Adaptimmune Therapeutics plc.US WorldMeds has entered into…
US WorldMeds Acquires Adaptimmune’s Cell Therapy Portfolio for $55 Million


Gibson, Dunn & Crutcher LLP has advised US WorldMeds on the transaction, and Ropes & Gray LLP has advised Adaptimmune Therapeutics plc.US WorldMeds has entered into…
…